Corrigendum to “Readers of DNA methylation, the MBD family as potential therapeutic targets” [Pharmacology & Therapeutics 184 (1) (2018) 98-111] (Pharmacology and Therapeutics (2018) 184 (98–111), (S0163725817302863) (10.1016/j.pharmthera.2017.11.002))